SPYRE THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 33.09 USD | +0.33% |
|
-8.31% | +53.76% |
| May. 15 | Spyre Therapeutics, Inc. Announces Board Changes | CI |
| May. 13 | Wells Fargo Adjusts Price Target on Spyre Therapeutics to $40 From $35, Maintains Overweight Rating | MT |
Quotes 5-day view
Delayed Quote Nasdaq| 2024-05-21 | 2024-05-22 | 2024-05-23 | 2024-05-24 | 2024-05-28 | |
|---|---|---|---|---|---|
| Last | 36.09 $ | 35.55 $ | 32.68 $ | 32.98 $ | 33.09 $ |
| Volume | 266 860 | 283 556 | 428 136 | 323 928 | 295 278 |
| Change | -2.12% | -1.50% | -8.07% | +0.92% | +0.33% |
| Opening | 36.30 | 35.97 | 35.75 | 32.68 | 33.53 |
| High | 37.35 | 37.75 | 36.79 | 34.00 | 33.87 |
| Low | 35.99 | 35.34 | 32.24 | 32.10 | 31.76 |
Performance
| 1 day | +0.92% | ||
| 1 week | -10.55% | ||
| Current month | -0.15% | ||
| 1 month | -1.73% | ||
| 3 months | +32.40% | ||
| 6 months | +174.60% | ||
| Current year | +53.25% | ||
| 1 year | +875.74% | ||
| 3 years | -80.49% | ||
| 5 years | -80.66% |
Volumes
marketsDaily volume
323 928
Estimated daily volume
323 928
Avg. Volume 20 sessions
290 912
Daily volume ratio
1.11
Avg. Volume 20 sessions USD
9 594 277.76
Record volume 1
10 228 381
Record volume 2
3 156 959
Record volume 3
2 233 298
Capital turnover ratio
0.01
Float rotation
0.01
Basic data
Capitalization (USD)
1 328 546 993
Net sales (USD)
886 000
Number of employees
30
Sales / Employee (USD)
29 533
Free-Float
88.69 %
Free-Float capitalization (USD)
1 178 324 940
Average Daily Capital Traded
0.72%
Highs and lows
1 week
32.10
37.75
1 month
31.3940.49
Current year
18.5447.97
1 year
2.6647.97
3 years
2.66212.50
5 years
2.66284.50
10 years
2.66318.75
Indicators
Moving average 5 days
34.83
Moving average 20 days
35.64
Moving average 50 days
36.56
Moving average 100 days
31.70
Price spread / (MMA5)
+5.62%
Price spread / (MMA20)
+8.08%
Price spread / (MMA50)
+10.85%
Price spread / (MMA100)
-3.89%
STIM
RSI 9 days
33.90
RSI 14 days
40.43
Sector Comparison - Bio Therapeutic Drugs
| Name | Change | 5d. change | 1st Jan change | 1-year change | Capi. | |
|---|---|---|---|---|---|---|
| +0.92% | -10.55% | +53.25% | +875.74% | 1.33B | ||
| +1.36% | +2.49% | +12.30% | +38.47% | 118B | ||
| +0.45% | -0.23% | +12.15% | +35.86% | 106B | ||
| -2.07% | +4.84% | -8.14% | -7.90% | 23.4B | ||
| -1.05% | +2.76% | -1.34% | -9.72% | 22.1B | ||
| +1.24% | -1.30% | -8.31% | -28.04% | 18.34B | ||
| -0.77% | -5.10% | -41.70% | -35.75% | 16.59B | ||
| -2.22% | -12.40% | -15.33% | -35.54% | 15.97B | ||
| -0.79% | -1.59% | +5.80% | +52.82% | 14.03B | ||
| -2.89% | -5.63% | +28.03% | -2.65% | 11.67B | ||
| +4.84% | -8.85% | -31.18% | -34.41% | 7.55B | ||
| -0.72% | -1.71% | -2.52% | +23.74% | 7.53B | ||
| -0.74% | -9.44% | +9.49% | +40.41% | 7.48B | ||
| +0.75% | +7.71% | +3.54% | +45.30% | 7.48B | ||
| +1.92% | -7.06% | +237.18% | +194.46% | 6.92B | ||
| -1.01% | -10.93% | -60.34% | -72.05% | 6.31B | ||
| Average | -0.05% | -3.72% | +12.06% | +67.55% | ||
| Weighted average by Cap. | +0.27% | -0.23% | +7.72% | +24.55% |
Historical data
| Date | Opening | High | Low | End-of-day | Volume |
|---|
Last transactions
7bff765982b.ypzA0qTQLXoZNkbGakg1FYje3VOFbDWviO319fPyvkg.jNfy5f2BZwNqUAG3UjxPLMSQ5SL3A1Df36qEubyb8hiQxbmelJ9PNS5acg
| Date | Price | Volume | Daily volume |
|---|---|---|---|
| 04:00:00 pm | 32.98 | 18,602 | 222,642 |
| 03:59:59 pm | 32.97 | 200 | 204,040 |
| 03:59:54 pm | 32.93 | 100 | 203,840 |
| 03:59:53 pm | 32.97 | 100 | 203,740 |
| 03:59:46 pm | 32.93 | 100 | 203,640 |
| 03:59:46 pm | 32.94 | 100 | 203,540 |
| 03:59:38 pm | 32.92 | 700 | 203,440 |
| 03:59:37 pm | 32.93 | 100 | 202,740 |
| 03:59:37 pm | 32.93 | 100 | 202,640 |
| 03:59:37 pm | 32.93 | 100 | 202,540 |
Monthly variations
Annual change
| 2024 | +53.25% | ||
| 2023 | +91.33% | ||
| 2022 | -90.53% | ||
| 2021 | -39.64% | ||
| 2020 | +3.01% | ||
| 2019 | +2.00% | ||
| 2018 | +38.45% | ||
| 2017 | +24.37% | ||
| 2016 | -63.72% |
- Stock Market
- Equities
- SYRE Stock
- Quotes Spyre Therapeutics, Inc.
